Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A von Heydebreck

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|July 27, 2001
Identifying splits with clear separation: a new class discovery method for gene expression dataA von Heydebreck, W Huber, A Poustka, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|August 8, 2006
Mathematical tree models for cytogenetic development in solid tumorsA von Heydebreck, B Gunawan, W Huber, et al.
Der Pathologe|August 18, 2010
[Multilayer analysis of signal transduction and cell cycle control in GIST. Identifying new interaction partners with differential regulation]F Haller, D J Zhang, C Löbke, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|March 22, 2003
Transcription profiling of renal cell carcinomaW Huber, J M Boer, A von Heydebreck, et al.
Cancer Research|November 3, 2001
Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosisB Gunawan, W Huber, M Holtrup, et al.
The Journal of Pathology|January 18, 2007
An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implicationsB Gunawan, A von Heydebreck, B Sander, et al.
Genome Research|November 3, 2001
Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA arrayJ M Boer, W K Huber, H Sültmann, et al.
The Journal of Pathology|April 29, 2008
Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs)F Haller, C Löbke, M Ruschhaupt, et al.
ESMO Open|May 14, 2024
First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 studyS P D'Angelo, C Lebbé, L Mortier, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|July 27, 2001
Identifying splits with clear separation: a new class discovery method for gene expression dataA von Heydebreck, W Huber, A Poustka, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|August 8, 2006
Mathematical tree models for cytogenetic development in solid tumorsA von Heydebreck, B Gunawan, W Huber, et al.
Der Pathologe|August 18, 2010
[Multilayer analysis of signal transduction and cell cycle control in GIST. Identifying new interaction partners with differential regulation]F Haller, D J Zhang, C Löbke, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|March 22, 2003
Transcription profiling of renal cell carcinomaW Huber, J M Boer, A von Heydebreck, et al.
Cancer Research|November 3, 2001
Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosisB Gunawan, W Huber, M Holtrup, et al.
The Journal of Pathology|January 18, 2007
An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implicationsB Gunawan, A von Heydebreck, B Sander, et al.
Genome Research|November 3, 2001
Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA arrayJ M Boer, W K Huber, H Sültmann, et al.
The Journal of Pathology|April 29, 2008
Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs)F Haller, C Löbke, M Ruschhaupt, et al.
ESMO Open|May 14, 2024
First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 studyS P D'Angelo, C Lebbé, L Mortier, et al.
Pageof 1